OMERS Administration Corp’s Royalty Pharma RPRX Stock Holding History

OMERS Administration Corp’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.48M	Buy	133,435 +54,128	+68%	+$2.82M	0.04%	224
2026 Q1	$3.8M	Buy	79,307 +9,712	+14%	+$425K	0.02%	337
2025 Q4	$2.69M	Buy	69,595 +53,687	+337%	+$2.05M	0.02%	328
2025 Q3	$561K	Hold	15,908	–	–	﹤0.01%	712
2025 Q2	$573K	Sell	15,908 -49,753	-76%	-$1.65M	﹤0.01%	627
2025 Q1	$2.04M	Buy	65,661 +8,453	+15%	+$268K	0.02%	385
2024 Q4	$1.46M	Sell	57,208 -23,804	-29%	-$631K	0.01%	415
2024 Q3	$2.29M	Hold	81,012	–	–	0.02%	352
2024 Q2	$2.14M	Buy	+81,012	New	+$2.25M	0.02%	366

Other funds holding RPRX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

OMERS Administration Corp's RPRX Position: Q2 2026 in Review

OMERS Administration Corp increased its Royalty Pharma (RPRX) stake by 68% in Q2 2026, buying an estimated $2.82M and bringing the position to 133,435 shares worth $7.48M. The position accounts for 0.04% of the portfolio, ranked #224.

OMERS Administration Corp first reported a position in RPRX in Q2 2024 and has held it in 9 quarters since. 645 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

OMERS Administration Corp held 133,435 shares of Royalty Pharma worth $7.48M as of Q2 2026.
OMERS Administration Corp bought 54,128 Royalty Pharma shares in Q2 2026, an estimated $2.82M.
Royalty Pharma made up 0.04% of OMERS Administration Corp's portfolio in Q2 2026, its #224 holding.
OMERS Administration Corp first reported a position in Royalty Pharma in Q2 2024 and has held it in 9 quarters since.
645 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on OMERS Administration Corp's 13F filing for Q2 2026, filed 13 Aug 2026.